GMP Human FGF-7 / KGF Protein (CHO)

DMF
Premium grade (Pre-GMP) version FG7-H5318 is now available for seamless transition.
1/8
+5 View all
製品番号/仕様
価格
Availability
数量
GMP-FG7H35-50ug
$600.00
In Stock - Delivery in 2-3 business days
GMP-FG7H35-500ug (50ug X 10)
$4,100.00
GMP-FG7H35-1mg (50ug X 20)
$6,300.00
GMP-FG7H35
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Product Details

KGF, also known as FGF-7, is a mesenchymal-derived growth factor belonging to the fibroblast growth factor (FGF) family, primarily known for its potent mitogenic effects on epithelial cells. In stem cell differentiation protocols, KGF signaling is critical for promoting the proliferation and expansion of pancreatic progenitor cells. Furthermore, it plays a key role in the subsequent maturation of these progenitors into endocrine precursors that will give rise to hormone-producing islet cells, including insulin-secreting beta cells.

Product Features and Advantages
  • Specific Endoderm Differentiation Driver​: Efficiently supports stem cell differentiation into definitive endoderm lineages, including pancreatic beta islet cells and other endodermal cell types.
  • Reliable Large-Scale Supply: Ensures consistent batch production capacity exceeding 1 gram, supporting robust scale-up for manufacturing.
  • Stringent Safety Profile​: Incorporates comprehensive virus testing, validation, and ultra-low endotoxin levels (< 0.01 EU/μg) to meet stringent quality standards.
  • Cost-Effective and Convenient​: Achieves up to 50% cost savings versus conventional alternatives, with simplified reconstitution in water instead of hydrochloric acid for ease of use.
GMP Platform Advantages
  • Quality Assurance: Global QMS with comprehensive and stringent QC release criteria.
  • End-to-End GMP Compliance: Full manufacturing and QC under a cGMP system.
  • Comprehensive Control of Adventitious Agents: Stringent biosafety from cell banks to final release.
  • Comprehensive Regulatory Support: Includes RSF and DMF to meet global requirements.
  • Resilient Supply Chain: Intelligent modular facilities ensure a stable global supply.
  • Professional Support: Extensive manufacturing and application expertise to accelerate development.
Source

GMP Human FGF-7 / KGF Protein (CHO) (GMP-FG7H35) is expressed from CHO cells. It contains AA Cys 32 - Thr 194 (Accession # P21781-1).

Predicted N-terminus: Cys 32

Molecular Characterization

This protein carries no "tag".

The protein has a calculated MW of 18.9 kDa. The protein migrates as 27 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin

Less than 10 EU/mg, tested by the rFC method in compliance with USP <86> and Ph. Eur. 2.6.32.

Host Cell Protein

<0.5 ng/µg of protein tested by ELISA.

Host Cell DNA

<0.02 ng/μg of protein tested by qPCR.

Sterility

Sterility testing was performed using the membrane filtration method in compliance with USP <71> and Ph. Eur. 2.6.1.

Mycoplasma

Negative

Purity

>95% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.

Contact us for customized product form or formulation.

Vial Specification

2R (13 mm neck finish)

Shipping and Storage

This product is supplied and shipped on blue ice.

Upon receipt, store it immediately at -20°C or lower for long term storage.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 5 years in lyophilized state;
  • -70°C for 12 months under sterile conditions after reconstitution.

バックグランド

Fibroblast growth factor (FGF) 7 (is also known as Keratinocyte growth factor (KGF)), a member of FGF family, is initially found to be secreted from mesenchymal cells to repair epithelial tissues. As a well-characterized paracrine growth factor for tissue growth and regeneration, fibroblast growth factor 7 (FGF7) is involved in a number of physiological and pathological processes, including lung disease and cancer. The stromal-derived FGFs, such as FGF7 and FGF10, control epithelial cell resident FGFR2IIIb activities, promote net tissue homeostasis, and restraint tumor cells from progression to malignancy.